Glaukos Corp (GKOS)
128.29
+0.81
(+0.64%)
USD |
NYSE |
Sep 27, 16:00
128.30
+0.01
(+0.01%)
After-Hours: 20:00
Glaukos SG&A Expense (TTM): 245.44M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 245.44M |
March 31, 2024 | 232.39M |
December 31, 2023 | 224.07M |
September 30, 2023 | 212.96M |
June 30, 2023 | 205.86M |
March 31, 2023 | 202.63M |
December 31, 2022 | 192.92M |
September 30, 2022 | 188.56M |
June 30, 2022 | 185.88M |
March 31, 2022 | 181.28M |
December 31, 2021 | 179.26M |
September 30, 2021 | 175.48M |
June 30, 2021 | 169.96M |
March 31, 2021 | 162.78M |
December 31, 2020 | 171.40M |
September 30, 2020 | 187.22M |
June 30, 2020 | 192.72M |
March 31, 2020 | 192.26M |
December 31, 2019 | 176.64M |
September 30, 2019 | 149.13M |
Date | Value |
---|---|
June 30, 2019 | 136.32M |
March 31, 2019 | 127.30M |
December 31, 2018 | 119.53M |
September 30, 2018 | 113.39M |
June 30, 2018 | 105.90M |
March 31, 2018 | 101.93M |
December 31, 2017 | 96.26M |
September 30, 2017 | 90.79M |
June 30, 2017 | 83.50M |
March 31, 2017 | 73.95M |
December 31, 2016 | 64.76M |
September 30, 2016 | 56.65M |
June 30, 2016 | 51.04M |
March 31, 2016 | 48.43M |
December 31, 2015 | 43.96M |
September 30, 2015 | 40.50M |
June 30, 2015 | 35.94M |
March 31, 2015 | 30.00M |
December 31, 2014 | 28.13M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
149.13M
Minimum
Sep 2019
245.44M
Maximum
Jun 2024
191.44M
Average
187.89M
Median
SG&A Expense (TTM) Benchmarks
Boston Scientific Corp | 5.431B |
Intuitive Surgical Inc | 2.036B |
Insulet Corp | 815.60M |
Tandem Diabetes Care Inc | 349.43M |
iRhythm Technologies Inc | 409.30M |